Genmab har netop præsenteret stærke data på Annual Meeting and Exposition of the American Society of Hematology (ASH). Hør mere i denne video med Helge Larsen.
Disclaimer: Dette er ikke en anbefaling om køb eller salg af aktien. Helge Larsen har aktier i Genmab.
Disclaimer: Dette er ikke en anbefaling om køb eller salg af aktien. Helge Larsen har aktier i Genmab.
12/12 2022 15:34 ProInvestorNEWS 5
108652 Genmab to Hold 2022 R&D Update and ASH Data Review Meeting
https://www.proinvestor.com/investornyt
https://www.proinvestor.com/investornyt
13/12 2022 07:10 Helge Larsen/PI-redaktør 3108674 2022 R&D Update and ASH Data Review
Dec 12, 2022 at 8:00 PM EST
Genmab hosted its 2022 R&D Update and ASH Data Review on Monday, December 12, 2022.
This meeting was not an official program of the ASH Annual Meeting.
https://www.proinvestor.com/investornyt/915182/december-12-2022-800-pm-est-2022-rampd-update-and-ash-data-review
Dec 12, 2022 at 8:00 PM EST
Genmab hosted its 2022 R&D Update and ASH Data Review on Monday, December 12, 2022.
This meeting was not an official program of the ASH Annual Meeting.
https://www.proinvestor.com/investornyt/915182/december-12-2022-800-pm-est-2022-rampd-update-and-ash-data-review
